Please select the option that best describes you:
At what cumulative anthracycline dose is it recommended to use dexrazoxane for cardioprotection?
Answer from: at Academic Institution
Dexrazoxane, an iron chelating agent that scavenges free radicals and reduces ROS generation, has been shown in multiple clinical trials and meta-analyses to decrease the risk of anthracycline-induced heart failure (Cardioprotective interventions for cancer patients receiving anthracyclines - PubMed...
Sign in or Register to read more